Abstract
Citation: Ozgu E (2014) Targeted Agents in Gynecologic Cancers. Obstet Gynecol Int J 1(1): 00006. DOI: 10.15406/ogij.2014.01.00006 Submit Manuscript | http://medcraveonline.com In 21st century, cancer has become one of the leading causes of death especially in developed countries. On the other hand, gynecologic malignancies take an important part in women cancers that uterine corpus and ovarian cancers are in the ten leading cancer types for both new cases and deaths. While endometrial cancer is the most common gynecologic malignancy, ovarian cancer has the greatest mortality rate among them. Additionally cervical cancer is tremendously increasing especially in low socioeconomic regions [1]. Although using surgery for primary treatment is still essential for especially gynecologic cancers, investigations are aimed for developing new treatment modalities for decreasing the mortality and morbidity due to malignancies.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
